AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimco M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Zatropha Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimco M 2mg/500mg Tablet ER

Diabex Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be limited due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before use. Pregnant or lactating women require medical consultation prior to initiating treatment. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Glimco M 2mg/500mg Tablet ER

Managing Type 2 diabetes

Major Benefits of Glimco M 2mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimco M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glimco M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimco M 2mg/500mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glimco M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Glimco M 2mg/500mg Tablet ER works:

Glimco M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimco M 2mg/500mg extended-release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimco M 2mg/500mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimco M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimco M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of this medication. Consult your physician. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimco M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. In individuals with mild to moderate hepatic dysfunction, initiation with a low dose of Glimco M 2mg/500mg Extended-Release tablets is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimco M 2mg/500mg Tablet ER :

Should you forget a Glimco M 2mg/500mg Extended-Release Tablet, take it immediately upon remembrance. If your next scheduled dose is imminent, however, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimco M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimco M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Glimco M 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimco M 2mg/500mg Tablet ER and seek immediate medical attention.
Glimco M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimco M 2mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimco M 2mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 at least annually is recommended by some researchers.
Glimco M 2mg/500mg Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimco M 2mg/500mg ER tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimco M 2mg/500mg Tablet...
104
MRP 120
13% off